BOGOTA, Colombia — Boston Scientific do Brasil Ltda., the Brazilian subsidiary of the med-tech multinational, has emerged as the first company linked to an investigation into possible cartel activities in the largest market in Latin America.

PARIS — To fund its ramp-up to market, artificial heart maker Paris-based Carmat SA raised €50 million ($55 million) through a reserved capital increase put together by a cluster of elite French institutional investors.